ASCO 2009: E-Review in Hematology |  | Dr. Steven T. Rosen |
Welcome. I am pleased to share with you my selection of the "Top 10" hematology abstracts presented recently at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), along with my perspective on these key studies.
Follow the links below to the body of the program presented in two parts: “Practical Implications for Today” and “Compelling Data for Tomorrow.” Each of these two sections includes summaries of 5 key abstracts and my commentary. I’m happy to share my thoughts on how these abstracts relate to your practice and, most importantly, your patients, as well as how the data may impact clinical care in the future.
I invite you to take a look, and hope you find this program both interesting and informative.
| |
Practical Implications for Today | In spite of significant advances in the understanding and treatment of hematologic malignancies over the past 5 years or so, these cancers remain challenges for clinicians. We always await the results of studies presented at the annual meeting of the American Society of Clinical Oncology (ASCO), hoping that they will be practice-changing for us and life-altering for our patients. Read More » | | | Compelling Data for Tomorrow | | Studies presented at this year’s ASCO annual meeting gave us a glimpse of the future, which looks promising with regard to improved treatments for the major hematologic malignancies. Several new compounds are in preliminary trials and others are on the fast track to approval, offering some very new options for attacking a variety of these cancers. Read More » |
|
|
|
